| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dinesh Thapa, Leon N Warne, Marco Falasc. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases. International journal of molecular sciences. vol 24. issue 19. 2023-10-14. PMID:37834122. |
nevertheless, the discovery of tetrahydrocannabinol (thc), the primary psychoactive compound in cannabis, and the endocannabinoid system renewed scientific interest in understanding the role of cannabis in modulating different conditions, including gastrointestinal disorders. |
2023-10-14 |
2023-10-15 |
Not clear |
| Jacob N Kisiolek, Victoria A Flores, Arjun Ramani, Blake Butler, James M Haughian, Laura K Stewar. Eight Weeks of Daily Cannabidiol Supplementation Improves Sleep Quality and Immune Cell Cytotoxicity. Nutrients. vol 15. issue 19. 2023-10-14. PMID:37836465. |
cannabidiol (cbd) is a non-intoxicating exogenous cannabinoid agonist derived from plants that, at high doses, has received fda approval as an anticonvulsant for epileptic seizures, and at low doses is marketed as a food-grade supplement for improved mental health, sleep quality, and immunological function. |
2023-10-14 |
2023-10-15 |
Not clear |
| Elisa Teichmann, Elane Blessing, Burkhard Hin. Non-Psychoactive Phytocannabinoids Inhibit Inflammation-Related Changes of Human Coronary Artery Smooth Muscle and Endothelial Cells. Cells. vol 12. issue 19. 2023-10-13. PMID:37830604. |
in view of the cardioprotective effects of cannabinoids described in recent years, the present study investigated the impact of the non-psychoactive phytocannabinoids cannabidiol (cbd) and tetrahydrocannabivarin (thcv) on proliferation and migration of human coronary artery smooth muscle cells (hcasmc) and on inflammatory markers in human coronary artery endothelial cells (hcaec). |
2023-10-13 |
2023-10-15 |
human |
| Peggy Arthur, Anil Kumar Kalvala, Sunil Kumar Surapaneni, Mandip Sachdeva Sing. Applications of Cannabinoids in Neuropathic Pain: An Updated Review. Critical reviews in therapeutic drug carrier systems. vol 41. issue 1. 2023-10-12. PMID:37824417. |
this review provides insights on the various preclinical and clinical therapeutic applications of cannabidiol (cbd), cannabigerol (cbg), and cannabinol (cbn) in various diseases and the ongoing clinical trials for the treatment of chronic and acute pain with cannabinoids. |
2023-10-12 |
2023-10-15 |
Not clear |
| Jefree J Raslan-Jaramillo, Gisela A Ríos-Gajardo, Marcia A Avello, Marta G de Dieg. Determination of cannabinoids in Cannabis sativa oil and infused ice cream by LC-DAD method. Journal of AOAC International. 2023-10-11. PMID:37819769. |
determination of cannabinoids in cannabis sativa oil and infused ice cream by lc-dad method. |
2023-10-11 |
2023-10-15 |
Not clear |
| Jefree J Raslan-Jaramillo, Gisela A Ríos-Gajardo, Marcia A Avello, Marta G de Dieg. Determination of cannabinoids in Cannabis sativa oil and infused ice cream by LC-DAD method. Journal of AOAC International. 2023-10-11. PMID:37819769. |
cannabis sativa is known to produce a class of terpenophenolic compounds named cannabinoids. |
2023-10-11 |
2023-10-15 |
Not clear |
| Bárbara Dos Anjos Rosário, Jéssica Alves Lemes, Maria Paula de Lima, Daniel Araki Ribeiro, Milena de Barros Vian. Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety. Reviews in the neurosciences. 2023-10-09. PMID:37812748. |
subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety. |
2023-10-09 |
2023-10-15 |
Not clear |
| Jacqueline Renee Kulbe, Alexandra Anh Le, Michael Mante, Jazmin Florio, Anna Elizabeth Laird, Mary K Swinton, Robert A Rissman, Jerel Adam Field. GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice. Journal of neurovirology. 2023-10-06. PMID:37801175. |
as cannabis is used at a higher rate in pwh compared to the general population, there is interest in understanding how hiv proteins and art drugs interact with the endocannabinoid system (ecs) and inflammation in the cns. |
2023-10-06 |
2023-10-07 |
mouse |
| Jie Li, Tengfei Gu, Shengping Hu, Baiye Ji. Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status. PloS one. vol 18. issue 10. 2023-10-05. PMID:37796968. |
cannabidiol (cbd), a major non-psychoactive constituent of cannabis, is a cannabinoid with anti-tumor properties but its effects on prostate cancer cells are not studied in detail. |
2023-10-05 |
2023-10-07 |
Not clear |
| Mostafa A Elhendawy, Mohamed M Radwan, Elsayed A Ibrahim, Amira S Wanas, Suman Chandra, Murrell Godfrey, Mahmoud A ElSohl. Validation and Quantitation of Fifteen Cannabinoids in Cannabis and Marketed Products Using High-Performance Liquid Chromatography-Ultraviolet/Photodiode Array Method. Cannabis and cannabinoid research. 2023-10-05. PMID:37797227. |
validation and quantitation of fifteen cannabinoids in cannabis and marketed products using high-performance liquid chromatography-ultraviolet/photodiode array method. |
2023-10-05 |
2023-10-07 |
Not clear |
| Yuxi Li, Xilin Li, Patrick Cournoyer, Supratim Choudhuri, Lei Guo, Si Che. Induction of apoptosis by cannabidiol and its main metabolites in human Leydig cells. Archives of toxicology. 2023-10-04. PMID:37794255. |
cannabidiol (cbd) is one of the most prevalent and abundant cannabinoids extracted from the plant cannabis sativa. |
2023-10-04 |
2023-10-07 |
human |
| Sophie G Coelho, Sergio Rueda, Cecilia T Costiniuk, Mohammad-Ali Jenabian, Shari Margolese, Enrico Mandarino, Paul A Shuper, Christian S Hendershot, John A Cunningham, Gordon Arbess, Joel Singer, Jeffrey D Wardel. Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary Study. International journal of behavioral medicine. 2023-10-04. PMID:37794278. |
knowledge of cannabinoid content among people living with hiv who use cannabis: a daily diary study. |
2023-10-04 |
2023-10-07 |
Not clear |
| Galaxie Story, Carrie-Ellen Briere, D Julian McClements, David A Sel. Cannabidiol and Intestinal Motility: a Systematic Review. Current developments in nutrition. vol 7. issue 10. 2023-10-03. PMID:37786751. |
cannabidiol (cbd) is a non-intoxicating cannabinoid extracted from the cannabis plant that is used for medicinal purposes. |
2023-10-03 |
2023-10-07 |
Not clear |
| Hind Ibork, Sara El Idrissi, Simo Siyanda Zulu, Robert Miller, Lhoussain Hajji, Annabelle Manalo Morgan, Khalid Taghzouti, Oualid Abbouss. Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors. Neurotoxicity research. 2023-10-02. PMID:37782433. |
effect of cannabidiol in lps-induced toxicity in astrocytes: possible role for cannabinoid type-1 receptors. |
2023-10-02 |
2023-10-07 |
Not clear |
| Alyssa Vanderziel, James C Anthony, David Barondess, Jean M Kerver, Omayma Alshaaraw. Nausea and Vomiting of Pregnancy and Prenatal Cannabis Use in a Michigan Sample. American journal of obstetrics & gynecology MFM. 2023-10-01. PMID:37778699. |
further, the relatively recent discovery of cannabinoid hyperemesis syndrome may contribute to the mischaracterization of morning sickness in individuals who use cannabis during pregnancy. |
2023-10-01 |
2023-10-07 |
Not clear |
| Saadet Inan, Sara J Ward, Citlalli T Baltazar, Gabrielle A Peruggia, Elham Javed, Ajay P Naya. Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation. International journal of molecular sciences. vol 24. issue 18. 2023-09-28. PMID:37762646. |
cannabis has a rich chemical profile including cannabinoids and terpenes that possess immunomodulatory potential. |
2023-09-28 |
2023-10-07 |
mouse |
| Saadet Inan, Sara J Ward, Citlalli T Baltazar, Gabrielle A Peruggia, Elham Javed, Ajay P Naya. Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation. International journal of molecular sciences. vol 24. issue 18. 2023-09-28. PMID:37762646. |
we examined whether major cannabinoids of cannabis such as cannabidiol (cbd) and the bicyclic sesquiterpene beta-caryophyllene (β-cp) act as contact sensitizers. |
2023-09-28 |
2023-10-07 |
mouse |
| Anna Stasiłowicz-Krzemień, Piotr Szulc, Judyta Cielecka-Pionte. Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from Pharmaceutics. vol 15. issue 9. 2023-09-28. PMID:37765249. |
co-dispersion delivery systems with solubilizing carriers improving the solubility and permeability of cannabinoids (cannabidiol, cannabidiolic acid, and cannabichromene) from cannabinoids: cannabidiol (cbd), cannabidiolic acid (cbda), and cannabichromene (cbc) are lipophilic compounds with limited water solubility, resulting in challenges related to their bioavailability and therapeutic efficacy upon oral administration. |
2023-09-28 |
2023-10-07 |
Not clear |
| Erin L Martin, Nathaniel L Baker, Cristina Sempio, Uwe Christians, Jost Klawitter, Aimee L McRae-Clar. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. Addiction biology. vol 28. issue 10. 2023-09-27. PMID:37753564. |
sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. |
2023-09-27 |
2023-10-07 |
human |
| Besma Benredjem, Graciela Pineyr. A type II cannabis extract and a 1:1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space. Frontiers in pharmacology. vol 14. 2023-09-25. PMID:37745077. |
a type ii cannabis extract and a 1:1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space. |
2023-09-25 |
2023-10-07 |
Not clear |